Head-to-head · WeighScore
HealthHub vs NexLife
The verdict
NexLife takes it — 68.7/100 to 56/100.
NexLife grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | HealthHub | NexLife |
|---|---|---|
| WeighScore | 56/100 | 68.7/100 |
| Grade | C | C |
| Scorecard rank | #424 | #139 |
| Semaglutide | Not disclosed | $165/mo (compounded) |
| Tirzepatide | Not disclosed | $215/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #424 · C
Strengths
- LegitScript Certified with a working verification link
- Six named pharmacy partners with city/state: AnazaoHealth (FL), Tailor Made (KY), Redrock (UT), Professional Arts (LA), Perfect RX (TX), Vios (MI)
- Oral dissolving tablet (ODT) form for both semaglutide and tirzepatide — rare in the DTC market
- No subscription required — lower commitment than auto-renewal competitors
- Cancellation policy linked publicly
Where it loses points
- Per-drug pricing isn't shown — gated behind signup
- Named medical director not disclosed — only a generic 'board-certified providers' claim
- Corporate legal entity not disclosed
- Full states-served list not shown — only testimonial cities (Austin, Miami, Denver)
- 503A vs 503B status not stated per pharmacy
Graded #139 · C
Strengths
- LegitScript certified platform
- Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
- Both semaglutide and tirzepatide at competitive pricing
- Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset
Where it loses points
- State availability not publicly disclosed
- Compounded only — no brand-name options
- Also covers hormone optimization and longevity
- Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.